Browsing by Author

A Comprehensive Biomarker Analysis of Microsatellite Unstable/Mismatch Repair Deficient Colorectal Cancer Cohort Treated with Immunotherapy

Elez Fernandez, Mª Elena; Mulet Margalef, Núria; Sanso Martinez, Miriam; Mancuso, Francesco Mattia; Ros Montañá, Fco. Javier; Argilés Martinez, Guillem; Martini, Giulia; Sanz Garcia, Enrique; Baraibar Argota, Iosune; Salva Ballabrera, Francesc; Noguerido Castro, Alba; Cuadra-Urteaga, Jose Luis; Fasani, Roberta; Garcia Rodriguez, Ariadna; Jiménez Catalan, Juan José; Aguilar, Susana; Hernandez Losa, Javier; Braña Garcia, Irene; Nuciforo, Paolo Giovanni; Tabernero Caturla, Josep; Salazar, Ramón; Vivancos Prellezo, Ana; Landolfi, Stefania; Comas Navarro, Raquel; Ruiz Pace, Fiorella; Dienstmann, Rodrigo (MDPI, 2022-12-21)

A signature of circulating microRNAs predicts the response to treatment with FOLFIRI plus aflibercept in metastatic colorectal cancer patients

Toledano, Marta; Gómez España, Maria Auxiliadora; Elez Fernandez, Mª Elena; Grávalos, Cristina; García-Alfonso, P.; Rodríguez, R.; Tabernero Caturla, Josep (Elsevier, 2023-03)

A transcriptomics approach to expand therapeutic options and optimize clinical trials in oncology

Lazar, Vladimir; Zhang, Baolin; Magidi, Shai; Raymond, Eric; Ducreux, M.; Felip Font, Enriqueta; Tabernero Caturla, Josep; Le Tourneau, Christophe (SAGE Publications, 2023)

Advances in immune checkpoint inhibitor combination strategies for microsatellite stable colorectal cancer

Ros Montañá, Fco. Javier; Balconi, Francesca; Baraibar Argota, Iosune; Salva Ballabrera, Francesc; Tabernero Caturla, Josep; Elez Fernandez, Mª Elena; Saoudi Gonzalez, Nadia (Frontiers Media, 2023-02-02)

Advances in the systemic treatment of therapeutic approaches in biliary tract cancer

Mirallas Viñas, Oriol; López-Valbuena, D.; García Illescas, David; Verdaguer Mata, Helena; Tabernero Caturla, Josep; Macarulla Mercadé, Teresa; Fabregat Franco, Carles (Elsevier, 2022-06)

Analysis of mutant allele fractions in driver genes in colorectal cancer - biological and clinical insights

Elez Fernandez, Mª Elena; Argilés Martinez, Guillem; Matos Garcia, Ignacio; Sanz Garcia, Enrique; Macarulla Mercadé, Teresa; Alsina Maqueda, Maria; Sauri Nadal, Tamara; Verdaguer Mata, Helena; Viaplana Donato, Cristina; García Palmer, Héctor; Nuciforo, Paolo Giovanni; Rodon Ahnert, Jordi; Vivancos Prellezo, Ana; Tabernero Caturla, Josep; Capdevila Castillon, Jaume; Landolfi, Stefania; Ruiz Pace, Fiorella; Ortiz Velez, Carolina; Dienstmann, Rodrigo (Wiley, 2017-06-15)

Antitumor activity of ipatasertib combined with chemotherapy: results from a phase Ib study in solid tumors

Isakoff, S. J.; Tabernero Caturla, Josep; Molife, L. R.; Soria, J.-C.; Cervantes, Andrés; Vogelzang, N. J.; Argilés Martinez, Guillem (Elsevier, 2020-05)

Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer: A Secondary Analysis of the AVANT Trial

Chibaudel, Benoist; Henriques, Julie; Rakez, Manel; Brenner, Baruch; Kim, Tae Won; Martínez-Villacampa, Mercedes; Tabernero Caturla, Josep (American Medical Association, 2020-10-19)

Back-to-back discovery, co-precision, and prevention

Casadei, Barbara; Tabernero Caturla, Josep (Oxford University Press, 2020-04)

Beyond the lessons learned from the COVID-19 pandemic: opportunities to optimize clinical trial implementation in oncology

Castelo-Branco, L.; Awada, Ahmad; Pentheroudakis, G.; Perez-Gracia, J. L.; Mateo Valderrama, Joaquim; Tabernero Caturla, Josep; Curigliano, Giuseppe (Elsevier, 2021-10)

Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring

Gyawali, B.; Dafni, U.; Amaral, T.; Barriuso, J.; Bogaerts, J.; Tabernero Caturla, Josep; de Vries, Elisabeth (BMJ, 2021-06)

Biomarker analysis beyond angiogenesis: RAS/RAF mutation status, tumour sidedness, and second-line ramucirumab efficacy in patients with metastatic colorectal carcinoma from RAISE-a global phase III study

Yoshino, T.; Portnoy, D. C.; Obermannova, Radka; Bodoky, György; Prausová, J.; Tabernero Caturla, Josep; Garcia-Carbonero, Rocio (Oxford University Press, 2019-01-01)

BRAF, MEK and EGFR inhibition as treatment strategies in BRAF V600E metastatic colorectal cancer

Ros Montañá, Fco. Javier; Baraibar Argota, Iosune; Sardo, Emilia; Mulet Margalef, Núria; Salva Ballabrera, Francesc; Argilés Martinez, Guillem; Martini, Giulia; Ciardiello, Davide; Tabernero Caturla, Josep; Elez Fernandez, Mª Elena (SAGE Publications, 2021-01)

Cancer Core Europe: A translational research infrastructure for a European mission on cancer

Eggermont, Alexander M M; Apolone, Giovanni; Baumann, Michael; Caldas, Carlos; Lorenzo, Francesco de; Tabernero Caturla, Josep; Celis, Julio E (Wiley Open Access, 2019-01-18)

Chemorefractory Gastric Cancer: The Evolving Terrain of Third-Line Therapy and Beyond

Alsina Maqueda, Maria; Diez Garcia, Marc; Tabernero Caturla, Josep (MDPI, 2022-03-10)

Clinical and exploratory biomarker findings from the MODUL trial (Cohorts 1, 3 and 4) of biomarker-driven maintenance therapy for metastatic colorectal cancer

Ducreux, M.; Tabernero Caturla, Josep; Grothey, Axel; Arnold, Dirk; O’Dwyer, P.; Gilberg, Frank (Elsevier, 2023-05)

Scientia. Dipòsit d'Informació Digital del Departament de Salut